Newsletter
#38, Dr. Mary Rozenman & Dr. Chris Probert, insitro

AWS Health Innovation Podcast

#38, Dr. Mary Rozenman & Dr. Chris Probert, insitro

insitro, a company re-imagining drug discovery and development by integrating machine learning and biology at scale
January 9, 2023

#38, Dr. Mary Rozenman & Dr. Chris Probert, insitro

Joe Shonkwiler is joined by Dr. Mary Rozenman, Chief Financial Officer and Chief Business Officer at insitro, and Dr. Chris Probert, senior machine learning scientist at insitro. insitro is a company re-imagining drug discovery and development by integrating machine learning and biology at scale.

Dr. Rozenman and Dr. Probert discuss how insitro’s discovery process can start on either the clinical or cellular side, why scale is so important in every aspect of insitro’s model, and why diversity of experience and background can be a powerful tool in solving hard problems.

Learn more about insitro (https://insitro.com/) and how AWS enables healthcare & life sciences startups to grow and thrive (https://aws.amazon.com/startups/ and https://aws.amazon.com/health/).

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
Nashville’s Opportunity: Eco-Action or Anxiety In this excerpt from a Climate x Health Twitter Spaces live chat, experts from Vanderbilt, Oak Ridge National Laboratory, and others discuss hope and want listeners to be energetic and reject “doomerism” while embracing reality and emphasizing teamwork without ego to accomplish individual and systemic goals. This conversation was hosted live from the AAMC conference in Nashville.